Global Ascites Market Research Report - Forecast to 2023

Publisher : Market Research Future Publication Date : Jan 19, 2018

Number of Pages : 122 Subcategory : Healthcare
Single User $ 4450
Multi User $ -
Global User $ 6250

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For smaller amount of fluid ultrasound, and CT scan are preferred.
    Notably, rising prevalence of cirrhosis, improvement in reimbursement policies, and increasing occurrence of cancer are promoting the growth of ascites market globally. Ascites is a major complication of cirrhosis and is also an important landmark of chronic liver disease in the natural history. The rising alcohol consumption directly leads to the rising hospitalized cases and mortality due to alcoholic liver cirrhosis. Rising prevalence of cirrhosis and its related complications directly promotes the growth of ascites market.
    However, complications associated with ascites treatment may hamper the market growth in coming future.
    The global ascites market is expected to reach USD 3710.4 million by 2023 from USD 2806.1 million in 2016. This market is expected to grow at a stable CAGR of 4.0% during the forecast period d 2017-2023.
    On the basis of type, the global ascites market is classified into transudative ascites, and exudate ascites. In 2016, exudate ascites segment commanded the largest market share of global ascites market by type segment.
    On the basis of diagnosis, the global ascites ultrasound, CT scan, laparoscopy, angiography, and others. Ultrasound segment commanded the largest market share of 25.9% in 2016, and this segment is also expected to grow at a fastest CAGR of 4.4% during the forecast period 2017 to 2023.
    On the basis of treatment, the global ascites market is segmented into surgeries, and others. Surgeries segment is further segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), others. The surgeries market is projected to reach USD 2119.2 million by the end of 2023 at the CAGR of 4.3% during 2017 to 2023.
    On the basis of end user, the global ascites market is segmented into hospitals & clinics, ambulatory surgical center, and diagnostic centers. The hospitals & clinics market is projected to reach USD 1,133.2 million by the end of 2023 at the CAGR of 4.4% during 2017 to 2023.
    On the basis of regions, the market is segmented into Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas hold the largest share of the global ascites market and is expected to reach USD 1,292.2 million by 2023. Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023
    Key Players
    Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.
    Study objectives
    • To provide comprehensive analysis of ascites industry and its sub-segments in the global market, thereby providing a detailed structure of the industry.
    • To provide detailed insights into the factors driving and restraining the growth of global ascites market.
    • To estimate the market size of global ascites from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.
    • To analyze global ascites market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.
    • To compare the products with respect to the various players in the market
    • To provide country wise market value analysis for various segments of ascites market
    • To understand the demand-supply scenario and provide gap analysis of the industry
    • To analyze and provide upcoming technologies and trends in ascites market
    • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.
    Target Audience
    • Ascites manufacturers
    • Ascites Suppliers
    • Ascites Distributors
    • Medical Device companies
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Academic Medical Institutes and Universities

    Key Findings
    • Americas accounted for the largest market share in the global ascites market, It is estimated to reach USD 1,292.2 million by 2023
    • Exudate ascites type of ascites is expected to command the largest market share of 55.8%
    • The ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023
    The reports also covers regional analysis
    • Americas
    o North America
     US
     Canada
    o South America

    • Europe
    o Germany
    o France
    o U.K.
    o Italy
    o Spain
    o Rest of Europe
    • Asia Pacific
    o Japan
    o China
    o India
    o Republic of Korea
    o Rest of Asia-Pacific
    • Middle East & Africa
    o Middle East
    o Africa

  • Table of Content

    Global Ascites Market Research Report - Forecast to 2023

    Table of Contents:

    1 Report Prologue
    2 Market Introduction
    2.1 Research Objective
    2.2 Assumptions & Limitations
    2.2.1 Assumptions
    2.2.2 Limitations
    2.3 Market Structure
    3 Research Methodology
    3.1 Introduction
    3.1.1 Primary Research Methodology
    3.1.2 Secondary Research Methodology
    3.1.3 Market Share Analysis
    3.1.4 Trade Analysis
    3.1.5 Market Pricing Approach
    4 Market Dynamics
    4.1 Introduction
    4.2 Drivers
    4.2.1 Rising Prevalence of Cirrhosis (Impact Weightage: 35%)
    4.2.2 Improvement in Reimbursement Policies (Impact Weightage: 30%)
    4.2.3 Increasing Occurrence of Cancer (Impact Weightage: 35%)
    4.3 Restraints
    4.3.1 Complications associated with the ascites treatment
    4.4 Opportunity
    4.4.1 Development of Innovative Treatment Options
    4.5 Macroeconomic Indicators
    5 Market Factor Analysis
    5.1 Porter’s Five Forces Model
    5.1.1 Bargaining Power of Suppliers
    5.1.2 Bargaining Power of Buyers
    5.1.3 Threat of New Entrants
    5.1.4 Threat of Substitutes
    5.1.5 Intensity of Rivalry
    5.2 Value Chain Analysis: Global Ascites Market
    5.2.1 R&D and Designing
    5.2.2 Manufacturing
    5.2.3 Distribution & Sales
    5.2.4 Post-sales Monitoring
    5.3 Demand & Supply: Gap Analysis
    5.4 Pricing Analysis
    6 Global Ascites Market by Types
    6.1 Introduction
    6.2 Transudative Ascites
    6.3 Exudate Ascites
    7 Global Ascites Market by Diagnosis
    7.1 Introduction
    7.2 Ultrasound
    7.3 CT scan
    7.4 Laparoscopy
    7.5 Angiography
    8 Global Ascites Market by Treatment
    8.1 Introduction
    8.2 Surgeries
    9 Global Ascites Market by End Users
    9.1 Introduction
    9.2 Hospitals & Clinics
    9.3 Ambulatory Surgical Center
    9.4 Diagnostic Centres
    10 Global Ascites Market by Regions
    10.1 Introduction
    10.2 Americas
    10.2.1 North America
    10.2.1.1 US
    10.2.1.2 Canada
    10.2.2 South America
    10.2.2.1 Brazil
    10.2.2.2 Colombia
    10.2.2.3 Mexico
    10.2.2.4 Rest of South America
    10.3 Europe
    10.3.1 Western Europe
    10.3.1.1 Germany
    10.3.1.2 France
    10.3.1.3 UK
    10.3.1.4 Italy
    10.3.1.5 Spain
    10.3.1.6 Rest of Western Europe
    10.3.2 Eastern Europe
    10.4 Asia Pacific
    10.4.1 China
    10.4.2 Japan
    10.4.3 India
    10.4.4 Australia
    10.4.5 Republic of Korea
    10.4.6 Rest of Asia Pacific
    10.5 Middle East & Africa
    10.5.1 Middle East
    10.5.1.1 UAE
    10.5.1.2 Saudi Arabia
    10.5.1.3 Oman
    10.5.1.4 Kuwait
    10.5.1.5 Qatar
    10.5.1.6 Rest of Middle East
    10.5.2 Africa
    11 Competitive Analysis
    11.1 Sequana Medical
    11.1.1 Company Overview
    11.1.2 Financials
    11.1.3 Products
    11.1.4 Strategy
    11.1.5 Key Developments
    11.2 BioVie
    11.2.1 Company Overview
    11.2.2 Financials
    11.2.3 Products
    11.2.4 Strategy
    11.2.5 Key Developments
    11.3 PharmaCyte Biotech Inc.
    11.3.1 Company Overview
    11.3.2 Financials
    11.3.3 Products
    11.3.4 Strategy
    11.3.5 Key Developments
    11.4 Fresenius SE & Co. KGaA
    11.4.1 Company Overview
    11.4.2 Financials
    11.4.3 Products
    11.4.4 Strategy
    11.4.5 Key Developments
    11.5 BD
    11.5.1 Company Overview
    11.5.2 Financials
    11.5.3 Products
    11.5.4 Strategy
    11.5.5 Key Developments
    11.6 GI Supply
    11.6.1 Company Overview
    11.6.2 Financials
    11.6.3 Products
    11.6.4 Strategy
    11.6.5 Key Developments
    11.7 Medtronic
    11.7.1 Company Overview
    11.7.2 Financials
    11.7.3 Products
    11.7.4 Strategy
    11.7.5 Key Developments
    12 Conclusion
    12.1 Key Findings
    12.1.1 From CEO’s View Point
    13 Appendix
    13.1 Discussion Blue Print

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.